Positive data for PTC124, one of the first potential therapies to address the basic defect in CF were published today in The Lancet. The Phase 2 data show that treatment with PTC124 improves the function of the faulty
|
1 min read
Share this article
Topics
About the CF Foundation
|
CFTR Modulators
|
Genetic Therapies
Teens Advocate for the PASTEUR Act as Part of the CF Foundation’s 14th Annual Teen Advocacy Day
News |
4 min read
CF Foundation Awards $1.6 Million to Improve Detection of Lung Transplant Complication
News |
5 min read
CF Foundation Announces New National Advocacy Chairs
News |
5 min read
Stay up to date with The Foundation
Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.